Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.200
-0.100 (-4.35%)
At close: Oct 26, 2026, 4:00 PM EDT
2.230
+0.030 (1.36%)
After-hours: Oct 26, 2026, 4:45 PM EDT
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $105.04 million as of October 26, 2026. It is the 24,481st most valuable company in the world and the 4,018th biggest in the United States. Its market cap has increased by 219.28% in one year.
Market Cap
105.04M
Enterprise Value
89.78M
1-Year Change
219.28%
Global Rank
Country Rank
#4,018 United States
Category
ChartMarket Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has decreased from $110.60M to $105.04M, a decrease of -5.02%. That is a compound annual growth rate of -0.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 105.04M | 273.82% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 120.35M |
| Humacyte | 119.93M |
| Foghorn Therapeutics | 118.77M |
| Kazia Therapeutics | 109.63M |
| Cibus | 107.76M |
| Black Diamond Therapeutics | 107.44M |
| Seer, Inc. | 107.42M |
| Unicycive Therapeutics | 107.24M |